PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
8.12%
Net income growth under 50% of CNQ's 1714.44%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
3.17%
Less D&A growth vs. CNQ's 6.90%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-144.13%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
No Data
No Data available this quarter, please select a different quarter.
-24.04%
Negative yoy working capital usage while CNQ is 84.72%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-24.04%
Negative yoy usage while CNQ is 84.72%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
17.70%
Lower 'other non-cash' growth vs. CNQ's 11472.19%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
1.12%
Operating cash flow growth below 50% of CNQ's 76.04%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
3.05%
Lower CapEx growth vs. CNQ's 32.77%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-176.63%
We reduce yoy sales while CNQ is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-44.23%
Both yoy lines negative, with CNQ at -169.48%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-117.85%
Both yoy lines negative, with CNQ at -14.77%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
88.59%
Debt repayment growth of 88.59% while CNQ is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-5.86%
Both yoy lines negative, with CNQ at -72.63%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
-11.86%
We cut yoy buybacks while CNQ is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.